Recommendations for antibiotic selection for severe nosocomial infections.
No Thumbnail Available
Identifiers
Date
2021-10-25
Authors
Mensa, J
Barberán, J
Ferrer, R
Borges, M
Rascado, P
Maseda, E
Oliver, A
Marco, F
Adalia, R
Aguilar, G
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Severe infection and its evolution to sepsis are becoming more prevalent every day and are among the leading causes of critical illness and mortality. Proper management is crucial to improve prognosis. This document addresses three essential points that have a significant impact on this objective: a) early recognition of patients with sepsis criteria, b) identification of those patients who suffer from an infection and have a high risk of progressing to sepsis, and c) adequate selection and optimization of the initial antimicrobial treatment.
Description
MeSH Terms
Anti-Bacterial Agents
Ceftazidime
Cephalosporins
Cross Infection
Humans
Tazobactam
Ceftazidime
Cephalosporins
Cross Infection
Humans
Tazobactam
DeCS Terms
CIE Terms
Keywords
antimicrobial treatment, ceftazidime-avibactam, ceftolozane-tazobactam, meropenem, optimization, sepsis, septic shock, severe infection